Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Obstet Gynecol ; 124(4): 735-742, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25198265

RESUMEN

OBJECTIVE: To evaluate whether ondansetron or the combination of doxylamine and pyridoxine was superior for the treatment of nausea and vomiting of pregnancy. METHODS: This was a double-blind, randomized, controlled trial in which women with nausea and vomiting of pregnancy were assigned to 4 mg of ondansetron plus a placebo tablet or 25 mg pyridoxine plus 12.5 mg of doxylamine for 5 days. The primary outcome was an improvement in nausea as reported on a 100-mm visual analog scale (VAS). Secondary outcomes were a reduction in vomiting on the VAS and the proportion of patients reporting sedation or constipation while using either study regimen. RESULTS: Thirty-six women (18 in each group) were randomized to either ondansetron or pyridoxine and doxylamine, of whom 13 (72%) and 17 (94%) completed follow-up, respectively. There were no differences among the groups with regard to demographic characteristics or baseline nausea. Patients randomized to ondansetron were more likely to have an improvement in their baseline nausea as compared with those using pyridoxine and doxylamine over the course of 5 days of treatment (median VAS score decreased 51 mm [interquartile range 37-64] compared with 20 mm [8-51]; P=.019). Furthermore, women using ondansetron reported less vomiting (median VAS decreased 41 [interquartile range 17-57] compared with 17 [-4 to 38]; P=.049). There was no significant difference between the groups regarding sedation or constipation. CONCLUSION: Our investigation showed ondansetron to be superior to the combination of pyridoxine and doxylamine in the treatment of nausea and emesis in pregnancy. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT01668069. LEVEL OF EVIDENCE: : I.


Asunto(s)
Doxilamina/administración & dosificación , Náuseas Matinales/diagnóstico , Náuseas Matinales/tratamiento farmacológico , Ondansetrón/administración & dosificación , Piridoxina/administración & dosificación , Adulto , Antieméticos/administración & dosificación , Método Doble Ciego , Quimioterapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Hiperemesis Gravídica/tratamiento farmacológico , Hiperemesis Gravídica/fisiopatología , Náusea/tratamiento farmacológico , Náusea/fisiopatología , Satisfacción del Paciente/estadística & datos numéricos , Embarazo , Medición de Riesgo , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Vómitos/tratamiento farmacológico , Vómitos/fisiopatología , Adulto Joven
2.
J Emerg Med ; 47(2): e49-51, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24877763

RESUMEN

BACKGROUND: Sialolithiasis with salivary gland obstruction can mimic more frequently occurring illnesses such as facial and dental infection and abscess. It is often difficult to discern the etiology of facial pain and swelling on physical examination alone, requiring advanced imaging in the emergency department. CASE REPORT: We describe the case of a 37-year-old man who presented with 5 days of worsening unilateral facial pain and swelling. Use of bedside emergency ultrasound by an emergency physician (EP) led to an appropriate diagnosis of parotid duct sialolithiasis. Why Should an Emergency Physician Be Aware of This? Use of bedside emergency ultrasound performed by a trained EP successfully diagnosed symptomatic sialolithiasis of the parotid duct in the emergency department without the need for computed tomography. The utility of bedside emergency ultrasound in the evaluation of sialolithiasis and the outcomes of our case are discussed here.


Asunto(s)
Enfermedades de las Parótidas/diagnóstico por imagen , Sistemas de Atención de Punto , Cálculos del Conducto Salival/diagnóstico por imagen , Enfermedad Aguda , Adulto , Humanos , Masculino , Ultrasonografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA